despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6....
"to be honest, that was what i had almost expected," she said..
he said: "greater and immediate attention needs to be applied in these two areas.".
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..
., and bones, and it�s not clear how the drugs will affect them after long-term use..